Navigation Links
Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
Date:3/13/2009

llular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the potential efficacy of R788 for the treatment of refractory or relapsed PTCL, Rigel's plans to pursue further clinical development of R788, enrollment rate in clinical trials of R788 and the timing of results thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "expects" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with the timing and success of clinical trials, potential problems that may arise in the clinical testing and approval process and Rigel's need for additional capital, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2008. Rigel does not undertake any obligation to update forward-looking statements.

    Contact: Raul Rodriguez
    Phone: 650.624.1302
    Email: invrel@rigel.com

    Media Contact: Susan C. Rogers, Alchemy Consulting, Inc.
    Phone: 650.430.3777
    Email: susan@alchemyemail.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
2. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
3. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
4. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
8. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
9. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
10. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
11. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter financial results on Tuesday, August 5, 2014, after ... host a live audio webcast immediately following the announcement ... business and financial update and discuss second quarter 2014 ... live audio webcast via the Investors & Media section ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 2014 Legislation backed by the drugstore ... Pharmacies Act of 2014") championing so-called "any willing ... the availability of lower cost preferred pharmacy networks ... the next 10 years, according to new research ... Care Management Association (PCMA). The drugstore ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... A unique collaborative effort among business leaders and health ... nation for health care has led to more than $12.8 ... days spent in the hospital and nearly 3,600 fewer adverse ... Solutions for Patient Safety initiative, launched in January 2009 ...
... Jan. 18, 2011 WebMD Health Corp. (Nasdaq: ... health information, has launched its Medscape from WebMD ... and tablets.  Medscape Mobile is the premier free ... professionals.  Since its release on the iPhone® and ...
Cached Medicine Technology:Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 2Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 3WebMD Launches Medscape for iPad™ and Android™ Devices 2WebMD Launches Medscape for iPad™ and Android™ Devices 3
(Date:7/22/2014)... By Steven Reinberg ... -- Women who are obese during pregnancy may be more ... new review suggests. "We found that, compared with children ... overweight or obese during pregnancy had up to 20 to ... Erick Forno, an assistant professor of pediatrics at Children,s Hospital ...
(Date:7/22/2014)... the University of Utah,s John A. Moran Eye Center, ... Research (ISER) as the recipient of the Houston, Texas-based ... Retina Research., The award recognizes lifetime achievement by a ... the understanding of vitreoretinal diseases or disorders. The award ... Meeting in San Francisco, where Marc will deliver a ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap Manchester ... MD. There has never been a better time in the ... success of the American national soccer team at the 2014 World ... that fans of the world’s sport will be able to feed ... Champions Cup. The tournament will kick off on July 24 and ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- One of the ... a psychiatric disorder has uncovered 83 new sites on ... The findings, made by an international team of researchers, ... linked to the disorder to 108. Although ... as a test to predict who will or will ...
Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... GPRC5A gene, which is under-expressed in human lung cancer cells, ... key to attacking lung cancer in humans, researchers at The ... the Nov. 21 edition of The Journal of the National ... of their GPRC5A genes suppressed developed normally until their second ...
... current laws are too cumbersome , , TUESDAY, Nov. 13 ... in their efforts to protect human research subjects, a ... doctors recently surveyed said that the Health Insurance Portability ... patients, medical information, has hindered research. Only one-quarter felt ...
... Sorting Out the Bitters , Maik Behrens, ... , The story goes that bitter taste receptors ... course, have diverse chemical structures. It has been debated ... whether we need multiple bitter receptors. Bitter taste is ...
... delivery ... technology., CLEVELAND, ... patented, 81 milligram aspirin tablet that,dissolves rapidly in the mouth instead ... of Americans who maintain a,daily aspirin routine and worry about gastrointestinal ...
... Heartburn Alliance Sponsors First Ever Heartburn Awareness Month, ... ... remains a burning problem,for more than 60 million Americans each month(1), ... for heartburn,education by sponsoring the first ever Heartburn Awareness Month. ...
... ... Tennis Champions, CHATHAM, N.J., Nov. 13 The Justin ... Jersey. The event will take place on two dates. On Sunday,December 9, ... tournaments with professional tennis champions. On Thursday,December 13, at 7 PM fans ...
Cached Medicine News:Health News:M. D. Anderson researchers identify tumor-suppressor gene for lung cancer 2Health News:Rules on Patients' Medical Data Hampering Research 2Health News:Rules on Patients' Medical Data Hampering Research 3Health News:News Tips from the Journal of Neuroscience 2Health News:News Tips from the Journal of Neuroscience 3Health News:New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:The Justin Gimelstob Children's Fund Hosts Tennis Exhibition 2
... is an intracorporeal electrokinetic lithotripter particularly ... VIBROLITH guarantees satisfaction in application to ... gall bladder and salivary gland stones. ... percutaneous applications. Kinetic energy transmitted by ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... Multiline offers an ideal combination of ... easy and effective treatment of urinary ... wide range of urological applications. ... images enabling rapid, precise stone localization. ...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: